Home/Filings/4/0000950170-25-006876
4//SEC Filing

SCLX Stock Acquisition JV LLC 4

Accession 0000950170-25-006876

CIK 0001820190other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 8:27 PM ET

Size

5.4 KB

Accession

0000950170-25-006876

Insider Transaction Report

Form 4
Period: 2025-01-16
Transactions
  • Other

    Common Stock

    2025-01-16779,37154,289,214 total
Footnotes (1)
  • [F1]Transferred in connection with a First Amendment to License and Commercialization Agreement (the "License Amendment") the Issuer entered into with Rxomeg Therapeutics, LLC a/k/a Romeg Therapeutics, LLC ("Romeg"), as contemplated by that certain Transfer Agreement entered into between the Issuer and Romeg (the "Transfer Agreement"). In consideration of the execution of the License Amendment and the Transfer Agreement, the Reporting Person transferred to Romeg an aggregate of 779,371 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person.

Documents

1 file

Issuer

Scilex Holding Co

CIK 0001820190

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001994894

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 8:27 PM ET
Size
5.4 KB